|
| |
MTU951
|
|
Recommended applications:
RNA or protein general tumor tissue profiling using IHC or ISH;
Antibody characterization.
Description:
40 types,
covering most of the common benign, malignant and metastatic
tumors originated from 27 anatomic sites. Majority of the tumors have
duplicates or triplicates from different individuals with corresponding
uninvolved tissues as controls. Most of the tissues were from surgical
resection. Those highlighted by '*" were from autopsy. All tissues were
fixed in 10% neutral buffered formalin for 24 hours and processed using
identical SOPs. Sections were picked onto Superfrost Plus or APES coated
Superfrost slides. They all have a guaranteed six months' shelf-life at
4C from the date of shipment. Each slide has >95% tissue core retention. |
|
| |
|
|
|
| |
|
Array
position |
Sex(es) |
Age(s) |
Anatomic site |
Histology |
Image |
|
A1,2,3 |
M,F,M |
36,38,47 |
Adrenal gland |
A1 -
normal, A2 - cortical adenoma, A3 - cortical carcinoma |
|
|
A4,5,6 |
M,M,F |
44,57,73 |
Bladder |
A4 - normal, A5, 6 -
transitional cell carcinoma |
|
|
A7,8,9,10,11, 12 |
F,F,F,F F,F |
28,22,43,35, 62,53 |
Breast |
A7 -
normal, 8,9 - adenoma, 10,11,12 - adenocarcinoma |
|
| B1,2 |
F,M |
23,39 |
Bone |
Osteosarcoma |
|
|
B3,4,5 |
M,F,F |
12,35,57 |
Cerebellum |
B3* -
normal, B4 - meningioma, B5- astrocytoma |
|
|
B6,7,8 |
M,M,F |
12,51,47 |
Cerebra (brain) |
B6*-
normal, B7 - meningioma, B8 - astrocytoma |
|
|
B9,10,11,12 |
F,F,M,M |
66,72,46,53 |
GI-Esophagus |
B9-
normal, B10,11,12 - squamous cell carcinoma |
|
|
C1,2,3,4 |
M,F,F,M |
39,51,66,72 |
GI-Stomach |
C1 -
normal, C2,3,4 - adenocarcinoma |
|
|
C5,6,7 |
F,F,M |
33,47,61 |
GI-Small intestine |
C5 -
normal, C6 - adenoma, C7 - adenocarcinoma |
|
|
C8,9,10,11,12 |
M,M,F,F, M |
55,69,61, 57,44 |
GI-Colon |
C8 -
normal, C9 - adenoma, C10,11,12 - adenocarcinoma |
|
|
D1,2,3,4 |
M,M,M,F |
37,35,50,69 |
GI-Rectum |
D1 -
normal, D2,3,4 - adenocarcinoma |
|
|
D5,6,7 |
M,F,M |
41,67,39 |
Kidney |
D5 -
normal cortex, D6,7 - clear cell carcinoma |
|
|
D8,9,10,11,12 |
F,F,M,M, M |
50,41,38, 33,57 |
Liver |
D8 -
normal, D9,10,11,12 - hepatocellular carcinoma |
|
|
E1,2,3,4,5 |
F,M,M,F,F |
50,47,63, 72,60 |
Lung |
E1 -
normal, E2,3 - squamous cell carcinoma, E4 - adenocarcinoma, E5
- small cell carcinoma |
|
|
E6,7,8,9 |
F,F,M,F |
38,73,53,39 |
Lymph
node |
E6 -
reactive, E7 - Hodgkin's, E8 - B-NHL, E9 - T-NHL |
|
|
E10,11,12 |
F,M,M |
47,65,31 |
Oranasopharynx |
E10 -
hard palate adenocarcinoma, E11- tongue squamous cell carcinoma,
E12 - NPC |
|
|
F1,2,3,4 |
F,F,F,F |
41,55,39,49 |
Ovary |
F1 -
normal, F2 - adenoma, F3,4 -adenocarcinoma |
|
| F5,6 |
M,M |
40,57 |
Pancreas |
F5 -
normal, F6 - adenocarcinoma |
|
|
F7,8,9 |
M,M,M |
59,63,67 |
Prostate |
F7 -
normal, F8,9 - adenocarcinoma |
|
|
F10,11,12 |
F,F,M |
29,41,59 |
Salivary gland |
F10 -
normal, F11 - pleomorphic adenoma, F12 - adenocarcinoma |
|
|
G1,2,3 |
F,F,M |
39,67,51 |
Skin |
G1 -
normal, G2 - squamous cell carcinoma, G3 - melanoma |
|
|
G4,5,6 |
M,M,M |
55,38,43 |
Testis |
G4 -
normal, G5,6 - seminoma |
|
|
G7,8,9,10,11, 12 |
F,F,F |
39,33,61 |
Thyroid |
G7 - normal, G8,9,10 - adenoma,
G11,12 - adenocarcinoma |
|
|
H1,2,3 |
F,F,F |
36,38,41 |
Uterus-cervix |
H1 - normal, H2,3 - squamous cell
carcinoma |
|
|
H4,5,6 |
F,F,F |
51,62,47 |
Uterus-endometrium |
H4 - normal, H5,6 - adenocarcinoma |
|
|
H7,8,9,10,11 |
M,F,F,M,F |
37,76,59, 80,70 |
H7 - liver, H8 - lung, H9 - lymph
node, H10 -lymph node, H11 - ovary |
Metastatic
cancers derived from - H7 - colon carcinoma, H8 - gastric
carcinoma, H9 - breast carcinoma, H10 - squamous cell carcinoma,
H11 - colon carcinoma |
|
|
|
+32 (0) 16
58 90 45 
+32 (0) 16
50 90 45
